Catalyst Wire Dossier Catalyst Wire Dossier

TI Inhalation Powder

Technosphere insulin · MannKind Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TI Inhalation Powder, covering 2014-10-16 to 2014-10-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study Designed to Compare 2 Dose Strengths of TI Inhalation Powder in Adults With Type 1 Diabetes Mellitus and to Compare One of Those Formulations (30Units) With an Injection of Insulin Lispro [Phase 2]

See pricing